Literature DB >> 31859142

Women and Cardiovascular Disease: Pregnancy, the Forgotten Risk Factor.

Clare Arnott1, Sanjay Patel2, Jon Hyett3, Garry Jennings4, Mark Woodward5, David S Celermajer2.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death and disability in women globally, accounting for 32% of deaths in females. There are several female-specific risk factors for CVD that are under appreciated clinically, insufficiently researched and not given adequate attention in CVD risk prediction. Hypertensive and metabolic disorders of pregnancy are independent risk factors for the development of premature CVD. They confer more than double the risk of CVD in exposed women, but are not included in any current, multivariable CVD risk prediction models. Failure to recognise this risk leads to a lost opportunity to identify at risk women, institute primary preventive strategies, and potentially improve their health trajectory. This also translates into a missed opportunity to educate women and their families about their CVD risks, and to a lack of awareness and prioritisation of CVD within the broader community. Improving CVD outcomes for women globally also requires attention to research methodology and analysis. Researchers should be encouraged to include a thorough pregnancy history in prospective CVD datasets and to power their studies to report on gender disaggregated CVD outcomes. Particular attention should be given to the inclusion of young women of child-bearing age in CVD intervention trials. Ultimately, women should be offered CVD assessment using gender specific risk prediction models that are validated across broad ethic and socioeconomic groups. These prediction models should account for female specific risk factors and their complex interactions with traditional risk factors. This will pave the way for a gender-specific approach to CVD diagnosis, investigation and management.
Copyright © 2019 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Pre-eclampsia; Pregnancy; Risk calculators

Year:  2019        PMID: 31859142     DOI: 10.1016/j.hlc.2019.09.011

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  7 in total

Review 1.  Hypertensive Disorders of Pregnancy and Heart Failure Risk.

Authors:  Sarah A Goldstein; Neha J Pagidipati
Journal:  Curr Hypertens Rep       Date:  2022-03-28       Impact factor: 4.592

2.  Does Adding Adverse Pregnancy Outcomes Improve the Framingham Cardiovascular Risk Score in Women? Data from the Tehran Lipid and Glucose Study.

Authors:  Marzieh Saei Ghare Naz; Ali Sheidaei; Ali Aflatounian; Fereidoun Azizi; Fahimeh Ramezani Tehrani
Journal:  J Am Heart Assoc       Date:  2022-01-11       Impact factor: 6.106

3.  Outcomes of ST-elevation myocardial infarction by age and sex in a low-income urban community: The Montefiore STEMI Registry.

Authors:  Anna E Bortnick; Muhammad Shahid; Sanyog G Shitole; Michael Park; Anna Broder; Carlos J Rodriguez; James Scheuer; Robert Faillace; Jorge R Kizer
Journal:  Clin Cardiol       Date:  2020-07-28       Impact factor: 2.882

4.  South Australian prospective cohort study evaluating outcomes of maternal kidney and cardiac disease in pregnancy: a protocol.

Authors:  Jarrad Hopkins; Erandi Hewawasam; Emily Aldridge; Prabha Andraweera; Shilpanjali Jesudason; Margaret Arstall
Journal:  BMJ Open       Date:  2022-02-14       Impact factor: 2.692

5.  Prevalence of Metabolic Syndrome in Women After Maternal Complications of Pregnancy: An Observational Cohort Analysis.

Authors:  Emily Aldridge; Maleesa Pathirana; Melanie Wittwer; Susan Sierp; Shalem Y Leemaqz; Claire T Roberts; Gustaaf A Dekker; Margaret A Arstall
Journal:  Front Cardiovasc Med       Date:  2022-03-14

6.  Effectiveness of a nurse practitioner-led cardiovascular prevention clinic at reduction of metabolic syndrome following maternal complications of pregnancy: a preliminary analysis.

Authors:  Emily Aldridge; Maleesa Pathirana; Melanie Wittwer; Susan Sierp; Shalem Y Leemaqz; Claire T Roberts; Gustaaf A Dekker; Margaret A Arstall
Journal:  Diabetol Metab Syndr       Date:  2022-10-06       Impact factor: 5.395

7.  Cardiovascular Risk Perception and Knowledge among Italian Women: Lessons from IGENDA Protocol.

Authors:  Silvia Maffei; Antonella Meloni; Martino Deidda; Susanna Sciomer; Lucia Cugusi; Christian Cadeddu; Sabina Gallina; Michela Franchini; Giovanni Scambia; Anna Vittoria Mattioli; Nicola Surico; Giuseppe Mercuro
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.